On the other hand, CAV1 acts as a promoter of metastasis in later stages of cancer, where enhanced expression of CAV1 favors the malignant phenotype and correlates with an increase in cell migration, metastasis [4–8], and multidrug resistance [9]. The gene discussed is CAV1; the disease is cancer.